Aspiriant LLC’s iShares Select Dividend ETF DVY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$978K Buy
6,259
+4
+0.1% +$616 0.02% 176
2026
Q1
$947K Buy
6,255
+4
+0.1% +$604 0.03% 159
2025
Q4
$882K Hold
6,251
0.03% 168
2025
Q3
$888K Hold
6,251
0.03% 155
2025
Q2
$830K Hold
6,251
0.03% 160
2025
Q1
$839K Buy
6,251
+147
+2% +$19.7K 0.03% 152
2024
Q4
$801K Hold
6,104
0.03% 160
2024
Q3
$824K Hold
6,104
0.03% 156
2024
Q2
$738K Hold
6,104
0.03% 164
2024
Q1
$752K Sell
6,104
-317
-5% -$37.1K 0.03% 162
2023
Q4
$753K Sell
6,421
-327
-5% -$36K 0.03% 162
2023
Q3
$726K Hold
6,748
0.04% 156
2023
Q2
$765K Sell
6,748
-5,040
-43% -$574K 0.04% 149
2023
Q1
$1.38M Buy
11,788
+575
+5% +$69.6K 0.07% 105
2022
Q4
$1.35M Sell
11,213
-436
-4% -$51.6K 0.07% 106
2022
Q3
$1.25M Sell
11,649
-251
-2% -$30.1K 0.06% 103
2022
Q2
$1.4M Sell
11,900
-591
-5% -$74K 0.07% 97
2022
Q1
$1.6M Sell
12,491
-909
-7% -$114K 0.09% 99
2021
Q4
$1.65M Buy
13,400
+2,965
+28% +$353K 0.09% 99
2021
Q3
$1.2M Hold
10,435
0.07% 107
2021
Q2
$1.22M Buy
10,435
+1,200
+13% +$143K 0.07% 100
2021
Q1
$1.05M Sell
9,235
-3,499
-27% -$370K 0.07% 102
2020
Q4
$1.23M Buy
12,734
+3,970
+45% +$360K 0.08% 87
2020
Q3
$714K Hold
8,764
0.06% 127
2020
Q2
$707K Hold
8,764
0.07% 111
2020
Q1
$645K Buy
8,764
+1,448
+20% +$138K 0.06% 108
2019
Q4
$773K Buy
7,316
+4,672
+177% +$481K 0.07% 109
2019
Q3
$270K Hold
2,644
0.02% 186
2019
Q2
$263K Sell
2,644
-50
-2% -$4.93K 0.02% 196
2019
Q1
$264K Hold
2,694
0.02% 196
2018
Q4
$240K Hold
2,694
0.02% 207
2018
Q3
$269K Hold
2,694
0.02% 208
2018
Q2
$263K Sell
2,694
-600
-18% -$58.2K 0.02% 217
2018
Q1
$313K Buy
+3,294
New +$322K 0.03% 190
2017
Q4
Sell
-2,694
Closed -$252K 106
2017
Q3
$252K Sell
2,694
-586
-18% -$54.2K 0.02% 179
2017
Q2
$302K Buy
3,280
+50
+2% +$4.6K 0.03% 170
2017
Q1
$294K Buy
+3,230
New +$292K 0.03% 173

Other funds holding DVY

Aspiriant LLC's DVY Position: Q2 2026 in Review

Aspiriant LLC increased its iShares Select Dividend ETF (DVY) stake by 0.06% in Q2 2026, buying an estimated $616 and bringing the position to 6,259 shares worth $978K. The position accounts for 0.02% of the portfolio, ranked #176.

Aspiriant LLC first reported a position in DVY in Q1 2017 and has held it in 37 quarters since. The position peaked at $1.65M in Q4 2021. 1,416 funds tracked by Wall St. Rank hold DVY as of Q2 2026.

  • Aspiriant LLC held 6,259 shares of iShares Select Dividend ETF worth $978K as of Q2 2026.
  • Aspiriant LLC bought 4 iShares Select Dividend ETF shares in Q2 2026, an estimated $616.
  • iShares Select Dividend ETF made up 0.02% of Aspiriant LLC's portfolio in Q2 2026, its #176 holding.
  • Aspiriant LLC first reported a position in iShares Select Dividend ETF in Q1 2017 and has held it in 37 quarters since.
  • Aspiriant LLC's iShares Select Dividend ETF position peaked at $1.65M in Q4 2021.
  • 1,416 funds tracked by Wall St. Rank held iShares Select Dividend ETF as of Q2 2026.

Based on Aspiriant LLC's 13F filing for Q2 2026, filed 20 Jul 2026.